Shanghai S.E.
06:00:00 2024-04-25 pm EDT
5-day change
1st Jan Change
8.21
CNY
0.00%
-3.86%
+17.12%
Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
April 27, 2020 at 02:57 pm EDT
Jointown Pharmaceutical Group Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 99,497.077 million compared to CNY 87,136.358 million a year ago. Operating income was CNY 2,301.417 million compared to CNY 1,829.953 million a year ago. Net income was CNY 1,726.549 million compared to CNY 1,340.578 million a year ago. Basic earnings per share from continuing operations was CNY 0.94 compared to CNY 0.73 a year ago. Diluted earnings per share from continuing operations was CNY 0.92 compared to CNY 0.72 a year ago.
Jointown Pharmaceutical Sets Up Joint AI Lab with Peking University's Wuhan Campus
Apr. 08
MT
Jiuzhoutong Pharmaceutical Investment Co., Ltd. announced that it expects to receive CNY 10.9100689 billion in funding from Jointown Pharmaceutical Group Co., Ltd
23-10-26
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-26
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-24
CI
Jointown Pharma's Unit Gets Nod for Registration of Acarbose Tablets
23-07-05
MT
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-24
CI
Nanjing IASO Biotherapeutics announced that it has received funding from Shanghai Chuanghehui Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
23-01-12
CI
Fujian Fukang Pharmaceutical Co., Ltd. announced that it has received funding from Shaoxing Shangyu Hangzhou Bay Economic Development Zone Holding Group Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
23-01-03
CI
Jointown Pharmaceutical Group Co., Ltd announces decision of Regulatory Authority on the transaction
22-12-12
CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
22-10-26
CI
Jointown Pharmaceutical Group Co., Ltd's Equity Buyback announced on April 26, 2022, has expired with 36,138,098 shares, representing 1.94% for CNY 425.67 million.
22-10-24
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-24
CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
22-10-10
CI
Jointown Pharmaceutical Group Co., Ltd announced that it expects to receive CNY 2.33 billion in funding
22-08-24
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-22
CI
Nanjing Puguang Biotechnology Co., Ltd announced that it has received $15 million in funding from Huatai Zijin Investment Co. Ltd, Nanjing XinGong Investment Group Co., Ltd, Shanghai Wenzhou Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
22-07-10
CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
22-07-01
CI
Amcare Lab announced that it has received $31 million in funding from Jointown Pharmaceutical Group Co., Ltd, Technology Financial Group, Fosun Group, K2VC, Bison Capital Asset Management, LLC, CICC Capital Management Co., Ltd.
22-06-08
CI
Jointown Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 600 million worth of its shares.
22-04-26
CI
Jointown Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.
22-04-25
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
22-04-25
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
22-04-25
CI
Binhui Biopharm announced that it has received $47.1 million in funding from Yangtze River Pharmaceutical Co., Ltd., DiNovA Venture Capital, Ming Capital, Jointown Pharmaceutical Group Co., Ltd, Hubei Provincial High and New Industry Investment Group Co., Ltd.
22-04-17
CI
Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
21-10-25
CI
Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
21-08-24
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.
More about the company
Last Close Price
8.21
CNY
Average target price
10.18
CNY
Spread / Average Target
+24.06%
Consensus
1st Jan change
Capi.
+17.12% 4.31B +17.35% 71.39B +5.38% 8.59B +6.69% 8.19B -20.96% 7.91B +0.49% 4.54B -3.38% 3.93B -2.61% 3.86B +22.08% 3.64B +7.96% 3.29B
Pharmaceuticals Wholesale
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
JOINTOWN PHARMACEUTICAL GROUP CO., LTD 
